DE50113102D1 - Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose - Google Patents

Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose

Info

Publication number
DE50113102D1
DE50113102D1 DE50113102T DE50113102T DE50113102D1 DE 50113102 D1 DE50113102 D1 DE 50113102D1 DE 50113102 T DE50113102 T DE 50113102T DE 50113102 T DE50113102 T DE 50113102T DE 50113102 D1 DE50113102 D1 DE 50113102D1
Authority
DE
Germany
Prior art keywords
tumor
markers
blood
relative
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50113102T
Other languages
English (en)
Inventor
Lan Dr Rer Nat Kluwe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Von Recklinghausen Gesellschaft eV
Original Assignee
Von Recklinghausen Gesellschaft eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Von Recklinghausen Gesellschaft eV filed Critical Von Recklinghausen Gesellschaft eV
Application granted granted Critical
Publication of DE50113102D1 publication Critical patent/DE50113102D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE50113102T 2000-06-27 2001-06-15 Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose Expired - Lifetime DE50113102D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113607 2000-06-27

Publications (1)

Publication Number Publication Date
DE50113102D1 true DE50113102D1 (de) 2007-11-22

Family

ID=8169084

Family Applications (1)

Application Number Title Priority Date Filing Date
DE50113102T Expired - Lifetime DE50113102D1 (de) 2000-06-27 2001-06-15 Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose

Country Status (4)

Country Link
US (3) US6660477B2 (de)
AT (1) ATE375404T1 (de)
DE (1) DE50113102D1 (de)
ES (1) ES2291246T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201400710A1 (ru) 2008-01-18 2015-03-31 Президент Энд Феллоуз Оф Гарвард Колледж Способы детекции признаков заболеваний или состояний в жидкостях организма
WO2009149166A2 (en) * 2008-06-03 2009-12-10 Children's Hospital Medical Center Methods and compositions for the diagnosis and treatment of proliferative disorders
US20120053073A1 (en) 2010-07-23 2012-03-01 President And Fellows Of Harvard College Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
KR20130041962A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 식작용 세포를 사용하여 질환 또는 상태를 검출하는 방법
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
WO2014164366A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting cancer
EP3385717A3 (de) 2013-03-09 2018-10-24 Harry Stylli Verfahren zum nachweis von prostatakrebs
DE102013221452B3 (de) * 2013-10-22 2015-02-26 Universitätsklinikum Hamburg-Eppendorf Verfahren zur Bestimmung der Wirksamkeit und/oder Spezifität eines Wirkstoffs
EP3693742B1 (de) 2014-09-11 2022-04-06 Harry Stylli Verfahren zum nachweis von prostatakrebs
US11104938B2 (en) 2017-06-20 2021-08-31 Bio-Rad Laboratories, Inc. Digital amplification assays for genetic instability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605799A (en) 1990-07-12 1997-02-25 University Of Utah Research Foundation Somatic mutations in neurofibromatosis type 1 gene in human tumors
US5707863A (en) * 1993-02-25 1998-01-13 General Hospital Corporation Tumor suppressor gene merlin
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
CN1128049A (zh) * 1994-03-18 1996-07-31 犹他大学研究基金会 多肿瘤抑制因子基因种系突变及检测该基因癌肿倾向性的方法
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene

Also Published As

Publication number Publication date
US20040091927A1 (en) 2004-05-13
US6660477B2 (en) 2003-12-09
ATE375404T1 (de) 2007-10-15
US20010055770A1 (en) 2001-12-27
US20110008773A1 (en) 2011-01-13
ES2291246T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
Faber et al. Value of diagnostic techniques for cutaneous leishmaniasis
Garcia et al. Effect of environmental factors on PCR-DNA analysis from dental pulp
DE50113102D1 (de) Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose
Truelsen et al. Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study.
NO972006D0 (no) Ny metode for diagnose av sykdommer
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
EP1813684A3 (de) Unterschiedlich exprimierte Gene in gesunden und kranken Individuen
WO2004075733A3 (en) Construction of a deafness gene chip
EP1441301A3 (de) Verfahren für das Identifizieren und das Kommunizieren mit möglichen Teilnehmern an klinischen Versuchen
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
KR102313455B1 (ko) 알츠하이머병 경도인지장애의 진단 또는 알츠하이머병 치매로의 진행 위험성 예측 방법
WO2002090583A3 (en) Skin treatment
KR102313460B1 (ko) 알츠하이머병 치매의 발병 위험성 예측을 위한 후성 유전학적 진단 키트 개발
Senst et al. Which tissue to take? A retrospective study of the identification success of altered human remains
WO2022186519A1 (ko) 호기 응축물 시료를 이용한 세균 메타게놈 분석 방법
ATE286253T1 (de) Methoden zur diagnose oder prognose der alzheimerschen krankheit
KR102139314B1 (ko) 유전자의 후성학적 메틸화 변화를 이용한 알츠하이머병 치매의 조기 진단 및 예측
KR102139313B1 (ko) 알츠하이머병 치매 조기 진단을 위한 후성 유전학적 진단 키트 개발
KR102313459B1 (ko) 알츠하이머병 치매 특이적 dna 메틸레이션 마커 검출용 조성물 및 검출방법
Pilli et al. Forensic Anthropology Issues: A Synergy between Physical and Molecular Methods: The Contribution of Degraded DNA Analysis to Physical and Forensic Anthropology
KR102313456B1 (ko) Naa60 유전자의 후성유전학적 변화를 이용한 알츠하이머병 치매 진단
KR102313458B1 (ko) 알츠하이머병 치매 관련 유전자 바이오마커 및 이의 이용
KR102313454B1 (ko) 유전자 CpG 메틸화 변화를 이용한 알츠하이머병 치매 진단용 조성물 및 이의 이용
CN107419028B (zh) 一种用于检测可变性红斑角化病的试剂盒及其应用
Arango Apoyo social, autoestima, eventos vitales y depresion: Un estudio longitudinal en muestras colombianas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8320 Willingness to grant licences declared (paragraph 23)